Immunome stock rallies 31% after antibody cocktail neutralizes Delta variant in pre-clinical testing

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Immunome stock rallies 31% after antibody cocktail neutralizes Delta variant in pre-clinical testing

To read the full story on Seeking Alpha, click here.

Immunome (NASDAQ:IMNM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Immunome Charts.

Immunome (NASDAQ:IMNM)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Immunome Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Immunome Inc News

More Immunome Inc News Articles

Valiant Eagle (PK)

Lehman Brothers Financial (CE)

Moon Equity (PK)

Atacama Resources (PK)

Baron Capital Enterprise (CE)

Bell Buckle (PK)

MicroCloud Hologram

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Virexit Technologies (PK)

Branded Legacy (PK)

Delayed Upgrade Clock